Company news
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class A (SSE:600332) news
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class A news releases on 6ix. Latest, Oct 29, 2025: Report for Q3 2025
View Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class A →
Press releases — page 2
Report for Q3 2025
October 28, 2025
Announcement on Subsidiary’s Drug Entering Phase III Clinical Trials
October 17, 2025
Announcement on Resolutions of the 29th Meeting of the 9th Board of Directors
September 28, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
September 26, 2025
Announcement on Subsidiary’s Drug Entering Phase II Clinical Trials
September 22, 2025
Announcement on Subsidiary’s Drug Entering Key Clinical Trials
September 15, 2025
Notice on Convening the 2nd Extraordinary General Meeting in 2025
September 5, 2025
Announcement on Subsidiary Obtaining Approval for Marketing of Chemical APIs
August 29, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
August 28, 2025
Announcement on the Completion of Private Fund Filing and Progress of Related Party Transactions
August 19, 2025
Full Text of 2025 Semi-annual Report
August 15, 2025
Announcement on Participation in the Investment and Establishment of Equity Investment Fund and Related Party Transactions
July 25, 2025
Announcement on Subsidiary Obtaining Drug Supplementary Application Approval
July 22, 2025
Announcement on Resolution of the 26th Meeting of the 9th Board of Directors
June 23, 2025
Announcement on Implementation of Dividend Distribution for 2024
June 12, 2025
Announcement on Resolutions of 2024 Annual General Meeting
June 3, 2025
Announcement on Obtaining Approval for Marketing of Chemical APIs by Branch
May 29, 2025
"Corporate Value and Return Enhancement" Action Plan 2025
May 28, 2025
Announcement on the Official Listing of Its Subsidiary Guangzhou Pharmaceutical Co., Ltd. on the National Equities Exchange and Quotations (NEEQ)
May 19, 2025
Notice on Convening the 2024 Annual General Meeting
May 12, 2025
Guangzhou Baiyunshan Phrmcl Hldgs : RESIGNATION OF A SUPERVISOR AND ELECTION OF A NEW SUPERVISOR
September 25, 2019
Guangzhou Baiyunshan Phrmcl Hldgs : PROPOSED DISPOSALS OF ACCOUNTS RECEIVABLES
September 10, 2019
Guangzhou Baiyunshan Phrmcl Hldgs : INSIDE INFORMATION PROPOSED SPIN-OFF AND OVERSEAS LISTING OF GUANGZHOU PHARMACEUTICAL CORPORATION ON THE STOCK EXCHANGE OF HONG KONG LIMITED
September 10, 2019